Research & Development



  紅袖搖頭道︰“沒有,不過啊,她家的水池子已經快要修好了,再有兩天就能往里面放水了。”   曹襄端起酒杯走到東方朔面前道︰“你是第二個與老虎相親而不畏懼的人,是真猛士,請滿飲此杯!”人人干免费在线视频   農夫們面朝黃土背朝天的勞作一天,吃一頓飽飯,然後就呼呼大睡,如果還有多余的精力跟興致或許還會干點別的,然後一天就算是過去了。男人的天堂VA网免费   曹襄在一邊顯擺著自己不多的一點板油大笑道︰“終于有一個比我瘦的了,哈哈哈,看你的樣子總讓我想起竹竿!”   不理睬就是阿嬌攆客人走的方式,她從小就這樣,並不因為高看雲瑯一眼就有所改變。2017亚洲男人天堂天堂   雲瑯木然的搖搖頭,然後就舉起了斧頭。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo